These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 282064)

  • 1. Antihypertensive activity of metyrosine in spontaneously hypertensive rats and its enhancement by carbidopa.
    Scriabine A; Ludden CT; Sweet CS; Porter CC; Ulm EH; Stone CA; Watkins CJ; Wurtman RJ; Cronin BL
    Clin Sci Mol Med Suppl; 1978 Dec; 4():255s-257s. PubMed ID: 282064
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of the anti-hypertensive effect of methyldopa and other anti-hypertensive drugs by carbidopa in spontaneously hypertensive rats.
    Scriabine A; Ludden CT; Stone CA; Wurtman RJ; Watkins CJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():407s-410s. PubMed ID: 1071655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive and noradrenaline-depleting effects of alpha-methyl-5-hydroxytryptophan in the rat.
    Tabei R; Spector S; Louis WJ; Sjoerdsma A
    Eur J Pharmacol; 1969 Jul; 7(1):39-44. PubMed ID: 5307150
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
    Cohen Y; Wepierre J; Jacquot C; Rapin J
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive effects of alpha-methylated catecholamine analogues in the rat.
    Brunner H; Hedwall PR; Maître L; Meier M
    Br J Pharmacol Chemother; 1967 May; 30(1):108-22. PubMed ID: 6039967
    [No Abstract]   [Full Text] [Related]  

  • 6. Involvement of dopamine in development of hypertension in spontaneously hypertensive rat: effect of carbidopa, inhibitor of peripheral dopa decarboxylase.
    Yoshimura M; Kambara S; Takahashi H; Okabayashi H; Ijichi H
    Clin Exp Hypertens A; 1987; 9(10):1585-99. PubMed ID: 3677444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive activity of 2-amino-4-(3,4-dichlorophenyl)-2-imidazoline (MJ 10459-2) and catecholamine reduction.
    Perhach JL; Gomoll AW
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):155-62. PubMed ID: 1188182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of hypotensive and anit-Parkinson effects with two dopaminergic drugs.
    Düby SE; Dahl LK; Cotzias GC
    Trans Assoc Am Physicians; 1971; 84():289-96. PubMed ID: 5164305
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-Hydroxytryptophan and carbidopa in spontaneously hypertensive rats.
    Itskovitz HD; Werber JL; Sheridan AM; Brewer TF; Stier CT
    J Hypertens; 1989 Apr; 7(4):311-5. PubMed ID: 2786023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antihypertensive drugs in the spontaneously hypertensive rat.
    Tabei R; Spector S; Louis WJ; Sjoerdsma A
    Clin Pharmacol Ther; 1970; 11(2):269-74. PubMed ID: 4392026
    [No Abstract]   [Full Text] [Related]  

  • 11. [The brain catecholaminergic system during the long-term correction of hereditary arterial hypertension].
    Maslova LN; Shishkina GT; Bulygina VV; Markel' AL; Naumenko EV
    Fiziol Zh Im I M Sechenova; 1996 Jan; 82(1):90-5. PubMed ID: 8829684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of decreased dopamine synthesis on the development of hypertension induced by salt loading in spontaneously hypertensive rats.
    Yoshimura M; Kambara S; Okabayashi H; Takahashi H; Ijichi H
    Clin Exp Hypertens A; 1987; 9(7):1141-57. PubMed ID: 3621632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological role of dopamine on the development of hypertension in rats.
    Yoshimura M; Kambara S; Okabayashi H; Ikegaiki I; Matsuzawa M; Suga K; Takahashi H; Ijichi H
    Jpn Circ J; 1987 Oct; 51(10):1226-31. PubMed ID: 3430692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of tissue norepinephrine and aortic pressure in spontaneously hypertensive rats by 1,2,3,5-tetrahydroimidazo(2,1-b)quinazoline.
    Buyniski JP; Cavanagh RL; Bierwagen ME
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):647-53. PubMed ID: 4701261
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
    Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of LY134046, an inhibitor of norepinephrine N-methyltransferase, in spontaneously hypertensive rats.
    Hahn RA; Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1983 Jul; 226(1):39-45. PubMed ID: 6864549
    [No Abstract]   [Full Text] [Related]  

  • 17. Tyrosine administration reduces blood pressure and enhances brain norepinephrine release in spontaneously hypertensive rats.
    Sved AF; Fernstrom JD; Wurtman RJ
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3511-4. PubMed ID: 291018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent.
    Korduba CA; Veals J; Wohl A; Symchowicz S; Tabachnick II
    J Pharmacol Exp Ther; 1973 Mar; 184(3):671-7. PubMed ID: 4687230
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of 6-hydroxydopamine on hypertension and noradrenaline content in the brain and heart of spontaneously hypertensive rats].
    Nikodijević O
    Acta Med Iugosl; 1975; 29(3):231-41. PubMed ID: 1146602
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of dopamine in the development of spontaneous hypertension.
    van den Buuse M; Versteeg DH; de Jong W
    Hypertension; 1984; 6(6 Pt 1):899-905. PubMed ID: 6519747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.